Clinical Trial Update: Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat [Phase 3]

View source ↗

Summary

Phase 3 trial of venglustat for Autosomal Dominant Polycystic Kidney Disease has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Congenital Cystic Kidney Disease

Drugs mentioned

• Venglustat (venglustat)

Snippet

Sponsor: Sanofi | Conditions: Congenital Cystic Kidney Disease | Phase 3 | Status: TERMINATED | Results posted: 2022-10-06